This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.
218763863

Only logged in users can watch the full video
A small part is available for preview

Only logged in users can watch the full video

Mid-term oncological results of TaTME

TaTME has gained acceptance as an alternative for the treatment of mid and low rectal cancer. However, mid and long-term data is still scarce. Dr. DeLacy described the current mid-term oncological outcomes at the Hospital Clínic in Barcelona.